Antidiabetic agent for control of diabetic hyperglycemia and...

Details Antidiabetic agent for control of diabetic hyperglycemia and... Antidiabetic agent for control of diabetic hyperglycemia and...

2011-07-05

2011-07-05

Solola, Taofiq A (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C549S039000

Reexamination Certificate

active

07973073

ABSTRACT:
Described herein is a compound of Formula I, which is the metformin salt of the naturally occurring endogenous biological compound, (R)-(+) α lipoic acid, pharmaceutical compositions containing the compound of Formula I, and methods of treatment of diabetes or diabetic complications with the compound of Formula I.

REFERENCES:
patent: 6572888 (2003-06-01), Byrd
patent: 2001/0028896 (2001-10-01), Byrd
patent: 2003/0078269 (2003-04-01), Pearson et al.
patent: 2003/0220301 (2003-11-01), Lal et al.
patent: 2003/0228362 (2003-12-01), Byrd
patent: 2005/0182029 (2005-08-01), Lal
patent: 2 796 551 (2001-01-01), None
patent: WO-99/61004 (1999-12-01), None
patent: WO-03/068209 (2003-08-01), None
patent: WO-2005/039539 (2005-05-01), None
International Search Report from PCT/US2007/014034, mailed Dec. 3, 2007.
Carlson et al., “The Plasma Pharmacokinetics of R-(+)-Lipoate to Healthy Human Subjects”,Alternative Medicine Review, 12:(4)343-351 (2007).

Affiliated with

Also associated with

Rating

Antidiabetic agent for control of diabetic hyperglycemia and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antidiabetic agent for control of diabetic hyperglycemia and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidiabetic agent for control of diabetic hyperglycemia and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2685266